3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Dermatologic
1
Conditions
Keratosis, Actinic
2
Keratosis
2
Precancerous Conditions
1
Neoplasms
1
Interventions
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Cyclophosphamide
2
Busulfan
2
Aminolevulinic Acid
2
tirbanibulin
1
ruxolitinib
1
fludarabine
1
Sirolimus
1
Robotic Surgical Procedures
1
Patient Reported Outcome Measures
1
Methotrexate
1
Mesna
1
Hysterectomy
1
Etoposide
1
Cyclosporine
1
CPI-0610
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
tirbanibulin
×
90 days
×
Clear all
NCT06135415
2026-03-25
TirbAKare
Almirall, S.A.
Phase 3
Completed
280 enrolled